Network Pharmacology-Based Prediction and Verification of the Targets and Mechanism for Panax Notoginseng Saponins against Coronary Heart Disease

Abstract EN

Coronary heart disease (CHD) is the worldwide leading cause for cardiovascular death.

Panax notoginseng saponin (PNS), which is the main bioactive compound of panax notoginseng, has been generally accepted to exert a remarkable effect on CHD for a long time.

However, to reveal the underlying treatment target and corresponding mechanism of PNS against CHD is still a substantial challenge.

In this work, the targets and mechanism of PNS against CHD were successfully achieved by pharmacology-based prediction and experimental verification.

36 common targets were screened out through integrating the gene expression profile of CHD and the chemical-protein data of PNS.

Then, two key nodes were further selected for verification by experiment after analyzing GO function, KEGG pathway, coexpression, and topology analysis.

Results showed that PNS has protected the human umbilical vein endothelial cells from H2O2-induced oxidative stress by inhibiting early cell apoptosis via upregulating VEGFA mRNA expression.

Therefore, our research has successfully pointed out one treatment target and apoptotic inhibition caused by PNS with method of integrating bioinformatics prediction and experimental verification, which has partially explained the pharmacological mechanism of PNS against CHD.